GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin
Combined Use of a Basal Insulin and Glucobay For Reducing PPG to End Diabetes Progress
2 other identifiers
observational
539
1 country
1
Brief Summary
To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 24, 2010
CompletedFirst Posted
Study publicly available on registry
November 25, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedJune 20, 2013
June 1, 2013
November 24, 2010
June 19, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in HbA1c
After 20 weeks
Secondary Outcomes (2)
Duration and dose of acarbose treatment
After 20 weeks
Postprandial Blood Glucose
After 20 weeks
Study Arms (1)
Group 1
Interventions
Adult female and male patients are scheduled to be treated with acarbose will be enrolled after the therapy decision has been made. Physicians should consult the full prescribing information for Glucobay® before enrolling patients and familiarize themselves with the safety information in the product package label.
Eligibility Criteria
Patients with DM in korea
You may qualify if:
- Signed written informed consent
- Age ≥ 18 years
- Diagnosed of type 2 diabetes for at least 6 months prior to enrollment
- Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months
- HbA1C≥7.5 and ≤10.0%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayerlead
Study Sites (1)
Unknown Facility
Many Locations, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bayer Study Director
Bayer
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 24, 2010
First Posted
November 25, 2010
Study Start
September 1, 2010
Study Completion
July 1, 2012
Last Updated
June 20, 2013
Record last verified: 2013-06